Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

2008 ◽  
Vol 59 (10) ◽  
pp. 1467-1474 ◽  
Author(s):  
Victoria Bejarano ◽  
Mark Quinn ◽  
Philip G. Conaghan ◽  
Richard Reece ◽  
Anne-Maree Keenan ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Early Rheumatoid Arthritis ◽  
Tumor Necrosis ◽  
Job Loss ◽  
Early Use ◽  
Necrosis Factor

scholarly journals Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

2007 ◽  
Vol 57 (8) ◽  
pp. 1564-1567 ◽  
Author(s):  
Richard J. Wakefield ◽  
Jane E. Freeston ◽  
Elizabeth M. A. Hensor ◽  
Domini Bryer ◽  
Mark A. Quinn ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Clinical Response ◽  
Early Rheumatoid Arthritis ◽  
Tumor Necrosis ◽  
Prolonged Treatment ◽  
Necrosis Factor

scholarly journals Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

2011 ◽  
Vol 64 (1) ◽  
pp. 42-52 ◽  
Author(s):  
Lotta Ljung ◽  
Julia F. Simard ◽  
Lennart Jacobsson ◽  
Solbritt Rantapää-Dahlqvist ◽  
Johan Askling ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Early Rheumatoid Arthritis ◽  
Acute Coronary Syndromes ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Inhibitors ◽  
Coronary Syndromes ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document